Prospective Study of Mylotarg and G-CSF in Acute Myeloid Leukemia Treatment
NCT01698879
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Novo Acute Myeloid Leukemia
Interventions
DRUG:
Mylotarg
Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias